BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
Long-Term Follow-Up of Anti-Mullerian hormone levels after laparoscopic endometrioma cystectomy
Shortly after our publication, very much to our surprise, R254X was also found in 3 different countries as far as in Western Asia and Middle East.13-16 The research team in Lebanon followed our protocol and showed that R254X in Lebanon patients had the same haplotype as ours
By incorporating protease-cleavable linkers into drug conjugates, it is possible to achieve a high degree of specificity, minimizing off-target effects and enhancing the therapeutic index of the drug
